T1	intervention 0 29	Progressive strength training
T2	condition 41 52	LYmphoedema
T3	duration 782 790	50 weeks
T4	outcome-Measure 960 971	feasibility
T5	outcome-Measure 1053 1065	satisfaction
T6	outcome-Measure 1070 1091	adherence to exercise
T7	outcome-Measure 1118 1149	arm interlimb volume difference
T8	outcome-Measure 1173 1188	muscle strength
T9	outcome-Measure 1233 1266	range of movement in the shoulder
T10	No-of-participants 1298 1303	eight
T11	No-of-participants 1307 1309	11
T12	outcome 1364 1375	dropped out
T13	outcome 1445 1468	high exercise adherence
T15	outcome 1698 1709	lymphoedema
T14	outcome 1565 1624	Program satisfaction was high and no serious adverse events
T16	outcome 1732 1766	Muscle strength markedly increased
T17	outcome 1856 1901	Range of shoulder movement was not negatively
